- Home
- ALEC vs CGO Comparison
ALEC vs CGO Comparison
Compare ALEC & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | CGO |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | 103 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 134.2M |
| IPO Year | 2019 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ALEC | CGO |
|---|---|---|
| Price | $1.54 | $12.94 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 879.4K | 29.4K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $10.71 |
| 52 Week High | $3.40 | $14.20 |
Technical Indicators
Market Signals| Indicator | ALEC | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 39.64 |
| Support Level | $1.37 | $12.14 |
| Resistance Level | $1.60 | $13.79 |
| Average True Range (ATR) | 0.14 | 0.26 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 18.71 | 21.57 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.